Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29056 | 158 | 29.2 | 39% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1399 | 7604 | INSULIN DEGRADING ENZYME//GLYCOSYLPHOSPHATIDYLINOSITOL//NEPRILYSIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERMEDIARY METABOLISM ENZYMES | Author keyword | 1 | 50% | 1% | 1 |
2 | NEUROSCI DOCTORAL SUBPROGRAM | Address | 1 | 50% | 1% | 1 |
3 | AURON MISHEIL THERAPY | Author keyword | 0 | 33% | 1% | 1 |
4 | BIJENICKA C 54 | Address | 0 | 33% | 1% | 1 |
5 | BIJENICKA 54 | Address | 0 | 20% | 1% | 1 |
6 | CHAIR GEN BIOL PARASITOL | Address | 0 | 20% | 1% | 1 |
7 | NUCL MED ONCOL CLIN | Address | 0 | 20% | 1% | 1 |
8 | IL2 RECEPTOR | Author keyword | 0 | 17% | 1% | 1 |
9 | MACROPHAGE ACCUMULATION | Author keyword | 0 | 13% | 1% | 1 |
10 | AURON MISHEIL THERAPY | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DE NOVO EMERGENCE | 2 | 67% | 1% | 2 |
2 | MELANOMA B16 | 1 | 50% | 1% | 1 |
3 | MALIGNANT HEMANGIOPERICYTOMAS | 0 | 25% | 1% | 1 |
4 | MURINE MYELOID LEUKEMIA | 0 | 14% | 1% | 1 |
5 | SPIN LABEL PROBE | 0 | 14% | 1% | 1 |
6 | THYMOMA BEARING MICE | 0 | 10% | 1% | 1 |
7 | MURINE MELANOMA B16 | 0 | 100% | 1% | 1 |
8 | TUMOR GROWTH REGULATION | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
INSULIN-CANCER RELATIONSHIPS - POSSIBLE DIETARY IMPLICATION | 1992 | 12 | 58 | 19% |
Activated T lymphocytes in type 2 diabetes: Implications from in vitro studies | 2003 | 34 | 39 | 21% |
The role of insulin-like growth factor 2 and its receptors in human tumors | 2002 | 26 | 114 | 11% |
Insulin resistance and atherosclerosis | 2006 | 139 | 178 | 3% |
Contributions to our understanding of T cell physiology through unveiling the T cell proteome | 2007 | 11 | 43 | 5% |
ESTROGEN USE AND CANCER RISK - A REVIEW | 1993 | 24 | 39 | 5% |
The role of hormones, growth factors and vitamins in carcinogenesis | 1996 | 6 | 231 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROSCI DOCTORAL SUBPROGRAM | 1 | 50% | 0.6% | 1 |
2 | BIJENICKA C 54 | 0 | 33% | 0.6% | 1 |
3 | BIJENICKA 54 | 0 | 20% | 0.6% | 1 |
4 | CHAIR GEN BIOL PARASITOL | 0 | 20% | 0.6% | 1 |
5 | NUCL MED ONCOL CLIN | 0 | 20% | 0.6% | 1 |
6 | GRACE DRUG CANC PHARMACOL | 0 | 100% | 0.6% | 1 |
7 | JORDANOVAC CLIN PULM DIS TB | 0 | 100% | 0.6% | 1 |
8 | REG IMMUNOL TRANSPLANTAT | 0 | 100% | 0.6% | 1 |
9 | TUMORKLIN SANAFONTIS | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000153153 | CYCLIC AMP ANTAGONIST//CYCLIC PIP//SCI PEDIAT ADOLESCENZA |
2 | 0.0000117729 | SHANNONS MUTUAL INFORMATION//FLORIDA RACING//COMPLETE DATA |
3 | 0.0000113924 | BB RAT//GIMAP5//IMMUNOGENET INFLAMMATORY DIS |
4 | 0.0000097421 | SPECIFIC BINDING SITES//BILE ACID PRODUCTION//CHRONIC AND ACUTE TREATMENTS |
5 | 0.0000090951 | BOVINE LYMPHOCYTE//LYT2//S METHYLTHIO CYSTEINE |
6 | 0.0000082046 | PLACENTAL INSULIN RECEPTORS//DIABET BRANCH BLDG 10 ROOM 8 S 243//HLTH SCI BIOMATH |
7 | 0.0000077397 | INSULIN DEGRADING ENZYME//NEPRILYSIN//INSULYSIN |
8 | 0.0000071515 | IR RAMAN GRP//CATALYTIC COPPER DEPOSITION//ELECTROMENISCUS PHENOMENON |
9 | 0.0000071242 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
10 | 0.0000065119 | LEPRECHAUNISM//INSULIN RECEPTOR//DONOHUE SYNDROME |